Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opinion & Analysis Teva Pharmaceutical Industries ADR Representing One TEVA

Healthcare
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the... see more

Opinion & Analysis (NYSE:TEVA)

    Gilead, Teva, XPhyto - Global marketing potential

    Mario Hose June 16, 2020

    The ASX: investing in an emerging biotech frontier

    The Life Sciences Report August 10, 2016

    An ETF That Provides Shelter From Stormy Markets

    Benzinga.com  September 3, 2015

    Buy biotech when there's blood on the street: Pontifax's Ran Nussbaum

    George S. Mack September 3, 2015

    Teva's Deal-Making Spurs Inflows To Israel ETFs

    Benzinga.com  August 3, 2015

    ETFs For The Next Pharma Takeover Candidates

    Benzinga.com  July 28, 2015

    ETF Outlook For Tuesday May 6, 2014 (EUFN, ITA, EIS, UAE)

    Benzinga.com  May 6, 2014

    Alaska gold prospectors could get some respect next week

    Thom Calandra March 19, 2010